Other Clinical Trial - Observational Study of Effect of NCT01546376

Clinical Trial Details — Status: Recruiting

Study information
Verified date	January 2009
Source	Rajavithi Hospital
Contact	Pathomphorn Siraprapasiri, MD
Phone	66-89-6662960
Email	spathomphorm[@]gmail.com
Is FDA regulated	No
Health authority	Thailand: Thai Society of radiation oncologyThailand: Rajavithi Hospital
Study type	Observational

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Recruitment information / eligibility
Status	Recruiting
Enrollment	100
Est. completion date
Est. primary completion date
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	Both
Age group	18 Years to 65 Years
Eligibility	Inclusion Criteria: - Age 18-65 years - HIV positive cancer patients - Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks Exclusion Criteria: - CD4 count < 200 cell/ml and not received anti retro viral

Time Perspective: Prospective

To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

Radiation:
• Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy

Other:
• Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

Locations
Country	Name	City	State
Thailand	Rajavithi Hospital	Bangkok

Sponsors *(1)*
Lead Sponsor	Collaborator
Rajavithi Hospital

Thailand,